Keep my session open?
Ending In 
The session is expired
Your session has expired. For your security, we have logged you out.
Would you like to log in again?

Common mistakes and tips when first moving into Oligonucleotide Analyses!

Webinar

Friday, 5th November, 2021
9:00 am to 10:00 am EST

Replay

Oligonucleotides have been gaining considerable interest over the last few years with the advent of gene therapy and mRNA vaccines. This increased need has many scientists transitioning from small molecule work into oligonucleotide therapeutics which pose several analytical challenges.

In this webinar, we will present:

  • How to avoid the common misconceptions surrounding the analysis of oligonucleotides
  • Discuss high-throughput synthetic oligonucleotides
  • Review an example of a complete workflow for mRNA sequencing


For more information, please contact us at webinar@avantorsciences.com.

Presented by:

Ken Cook

Dr. Ken Cook’s began his career in academia as a Biochemistry lecturer focused on protein chemistry and metabolism. Today, with well over thirty years’ industry experience working for Dionex, then Thermo Fisher Scientific, his vast knowledge supporting and developing solutions within chromatography brand him a bio-separations expert.

Ken’s work covered several application fields with a variety of analytical equipment. Initially using HPLC, Ion chromatography, SFC and capillary electrophoresis to develop new methods of analysis. This was a strong analytical introduction with multiple orthogonal techniques. Following his move into a Bio-Separations role with metabolomics, lipodomics and proteomics with nanoLC, all coupled to several MS systems. This work has always included strong collaborations with other groups throughout Europe and the supervision of several PhD studentships. Publications have been in a number of diverse fields including environmental, oil, food safety and adulteration, Proteomics, Protein chemistry, metabolomics and lipodomics.

Currently, his work involves the support of Bio-Pharmaceutical applications to characterise protein and oligonucleotide-based bio-therapeutics. This involves ongoing collaborations with the Biopharmaceutical industry and academia. Methods for the characterisation of therapeutic proteins include peptide mapping by LC/HRMS. Developments in charged variant analysis including novel coupling to MS, Glycan analysis, Aggregate analysis and on-line process monitoring. Gene therapy characterisation is a growing interest which has had much success.